Projects Portfolio


(A Constituent College of Tumaini University Makumira)


1Long-lasting treatments for nets and spraying and other material used in malaria vector control and personal protectionFranklin MoshaMark Rowland, Richard OxboroughIVCCSept.2011Sept. 2021
2Phase III Evaluation of Dawa Plus 2.0, long-lasting treatment for netsFranklin MoshaMark Rowland, Richard OxboroughWHOPESSept.2011Sept. 2021
3Genetic Susceptibility to scarring TrachomaMathew BurtonAthuman MchanaLSHTM,WELLCOME TRUSTAug.2011Aug. 2021
4The immunological determinant of protective immunity and immunopathologyMathew BurtonAthuman MchanaLSHTM,WELLCOME TRUSTAug.2011Aug. 2021
5Determining the prevalence of alcohol intoxication and high-risk alcohol behavior amongst adult injury patients at KCMCBlandina MmbagaCatherine Lynch,Charles Gerrardo,Nathan ThielmanNIHJune,2012Ongoing
6Impaact and ecology of bacterial zoonoses in Northern TanzaniaBlandina MmbagaKazwala,John CrumpNIHAug.2014Aug. 2021
7Knowledge, attitude, and practice of health care practitioners at KCMC on at-risk alcohol behavior amongst their patientsBlandin MmbagaCatherine Lynch,Charles Gerrardo,Neel KapadiaNIHAug.2012Ongoing
8Establishing Mental Health Needs in HIV Positive Adolescents in TanzaniaAisa shayoAnn Buchanan,Doroth DowDuke Peadiatric Infectious ClinicAug.2012Ongoing
9Identification and Intervention for people with Dementia in Africa (IDEA Study)Declare MushiAdesola Ogunniyi,Richard Walker,Sarah MkendaGrand Challenges CanadaMay,2013Ongoing
10Evaluation  of a novel long-lasting insecticidal and indoor residual spray product, separately and together, against malaria transmitted by parathyroid resistant mosquitoesFranklin MoshaWilliam Kisinza,Mark Rowland,Natacha ProtopopoffMedical Research Council and Welcome TrustApril,2015Ongoing
11Unraveling the role of interleukin 32 in HIV related Kaposi SarcomaGeorge SemangoGibson KibikiCOSTECHOct.2014Ongoing
12Assessment of prevention of mother to child HIV transmission program among fishing communities of lake victoria in TanzaniaMaseke MgaboSia Msuya, Declare MushiInstitute of Rural development and planningNovember,2014Ongoing
13IMPAACT P1093: Phase 1/11, Multicentre, Open-label, Pharmacokinetic, Safety, tolerability and antiviral activity of GSK 1349572, a novel intergrase inhibitor in combination regimens in HIV-1 infected infants, children, and adolescentsBlandina MmbagaJames Ngocho,Boniface Njau,Coleen CunninghamThe Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIAD)16th April,20152021
14Integrating Mental Health into an HIV clinic to improve outcomes among TanzaniaBlandina MmbagaAisa Shayo,Dr.Dorothy DowUS National Institute of Health and Fogarty InternationalJune,2015June, 2021
15HIV testing Preferences in TanzaniaBernard NjauJan Ostermann,Nathan ThielmanNational Institute of Allergy and Infectious Disease15th December,2011Ongoing
16Esophageal Squamous cell carcinoma African Preventive Effort (ESCAPE) TanzaniaBlandina MmbagaAmos MwasamajaESCAPEJun-16ongoing
17A Phase 1V Randomized Trial to Evaluate the Virologic response and pharmacokinetics of two different potent regimens in HIV Infected women initiating triple  antiretroviral regimens between 28 and 36 weeks of pregnancy for the prevention of mother to child transmission: NICHD P1081 Version Dated 2nd April 2015Blandina MmbagaJames NgochoThe Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIAD)June,2015June, 2021
18A5300/IMPAACT 2003 PHOENix Feasibility Study of MDRTB cases and their household contact: Operational feasibility to inform PHOENix Trial DesignBlandina MmbagaJames Ngocho and Boniface NjauUS National Institute of HealthDecember,2015December,2021
19P1097 Raltegravir pharmacokinetics and safety in neonates, version 2.0 dated 22nd January 2014Blandina MmbagaJames Ngocho,Boniface Njau,Coleen CunninghamUS National Institute of Healthoctober,2015October, 2021
20Evaluation of Portable Eye Examination Kit (PEEK) for the diagnosis of diabetic retinopathy in Kilimanjaro Region TanzaniaWilliam MakupaMathew Burton Heiko Phillipin christopher Mwansanso,Japhet Bright and Tara MtuyLSHTMMar-16Mar-21
21Kilimanjaro Microbial Keratitis StudyWilliam MakupaMuna Elisante,Athuman Ramadhani Heiko Philipin,Japhet Bright,Tara Mtuy,Joshua WilkesLSHTMMar-16Mar-21
22Factors influencing effective linkage of newly diagnosed HIV/AIDS client from point of testing to care and treatment clinics in Tanga region, Tanzaniajames ngochoDavid Kayabu ,Blandina MmbagaMEASURE Evaluation Ongoing
23Diagnostics and Pharmacotherapy fo severe forms of TuberculosisStella MpagamaEsto MdumaUniversity of Virginia Ongoing
24Identification of HIV dementia in Sub Saharan AfricaSarah UrassaDeclare Mushi,Stellla Maria PaddickUniversity of New CastleDecember,2018December,,2021
25Investigating the effect of patient-initiated repackaging of antiretroviral drugs  among HIV Infected patients attending care and treatment centers in northern TanzaniaSeleman Semvua NIHJanuary,2016January,2021
26Tumor-infiltrating lymphocytes as a potential biomarker in breast cancer in TanzaniaAlex Mremi NICHD and  NIAIDJanuary,2016Ongoing
27Impaact 2010 phase III study of the virologic efficacy and safety of dolutegravir containing versus efavirenz containing antiretroviral therapy regimens in HIV-1 infected pregnant women and their infants’ version 1.0,1 December 2016James Samwel NgochoPendo Mlay,Boniface Njau,Peter Sweya,Hans Maro,Seleman Semvua ,Coleen Cunningham  Ongoing
28Molecular epidemiology  of Bacillus Anthracis (MEBA) capacity, data and techniques for local surveillance in TanzaniaTiziana LemboTaya Forde,Ruth Zadoks,Roman Bilk  ,Olubunmi,Rhoda Amiru  Ongoing
29DCE-Impact; does preference-based HIV testing increase uptake in high-risk populations?Bernard NjauMartha Masaki,Elizabeth Mbuya,Beatrice Mandao,Honoratha Israel,Yambya Madulwa,Zuhura lintu,Dafrosa itemba,Dr.Eligy  Ongoing
30Molecular epidemiology of multidrug-resistant mycobacterium tuberculosis in Northern TanzaniaJohn Chale MgogweJaffu Chilongola,Hadija Semvua,Balthazar Nyombi  Ongoing
31Evaluation of samba semi-quantitative point of care viral load test for antiretroviral therapy monitoring in Moshi municipal TanzaniaIrene KiweluZahra Theilgaard,Eva Muro,Rachel Manongi,Neha Goel,Terese Keitzenstein,Dr.Helen Lee  Ongoing
32Prevalence of high-grade cervical lesions and persistence patterns of high-risk HR-HPV infection among HIV positive and HIV negative women in Kilimanjaro and Dar es salaamPatricia Samwel SwaiSia E Msuya  Ongoing
33Establishing a cancer center at KCMC scientific workup of the implementation phase of the first comprehensive cancer treatment facility in Northern Tanzania. Patient’s characteristics, patient management, knowledge, attitude and practices of medical staff use of pharmaceuticals palliative care practice    Ongoing
34IMPAACT 2005; A Phase 1/11 open-label,single-arm study to evaluate the pharmacokinetics, safety and tolerability of delamanid in combination with an optimized multidrug background regimen ( OBR) in HIV infected and uninfected children with MDR TB version 1.09th March 2017Hans Prosper ShayoStella Mpagama,boniface njau,peter sweya,aisa shayo,peter karoli and coleen cunningham July,2017Jul-21
35Investigation of the insecticide resistance status of the tropical bedbug cimexhemipterus in Muleba Tanzania.Its prevalence in households and the prospect for infestation control using new types of long-lasting insecticidal net being proposed for malaria controlFranklin MoshaMark Rowland and Natacha protopopoff July,2017Jul-21
36Arboviral disease surveillance,Aedes mosquito larval ecology and control strategies in Unguja Zanzibar; An investigative study using dengue as a caseFatma Hamis SaleheJovin Kitau,Karin linda SchiolerBSUAugust,2017Aug. 2021
37Understanding modifiable factors associated with childhood  overweight and obesity in Tanzania primary schools: Establishing a foundation for evidence-based obesity prevention interventionMary Vicent MoshaSia E Msuya, Suzanne Filteau,Heiner Grosskurth,Mary StoryTHRive ConsortiumAugust,2017Aug. 2021
38Evaluation of tuberculosis management  and tuberculosis prevention using isoniazid among individuals enrolled in HIV care and treatment services in Tanzania 2012 – 2015Werner Meinrad MaokolSia Msuya, Micheal Johnson Mahande, Dr.Bernard James Ngowi September,2017Ongoing
39Effect of reminder cues and tailored feedback on adherence to antiretroviral drug treatment  among people living with HIV/AIDS in the Kilimanjaro region, TanzaniaMarion SumariKennedy Ngowi,Eva Muro,Blandina Mmbaga,Godfrey Kisigo,Pythia Nieuwkerk,Mirjam Sprangers,Andre Vander ven,Rob Aarnoutse September,2017Sept. 2021
40Retention in PMTCT care and PMTCT outcomes using routinely collected aggregate and individual observation data in TanzaniaProsper Faustine NjauMicheal Mahande,Jim Todd,Jenny Renju,Jeffrey Eaton September,2017Sept. 2021
41The simulated ocular surgery (SOS) Trials: Randomised controlled trials comparing simulation-based surgical education for cataract and glaucoma surgery to conventional training alone in East AfricaWilliam MakupaWilliam Dean,Mathew Burton,Simon Arunga,John Buchan,Colin Cook,Stephen Gichuhi Juliet Otit December,2019December,2021
42Evaluating strategies to increase HIV testing uptake: Targeting alcohol-serving establishments and probing incentive testingBernard NjauDeng Madut,Nathan Thielman  December, 2021
43Molecular analysis of HIV 1 drug resistance mutations among patients failing first and second-line antiretroviral therapy in Kilimanjaro, TanzaniaIreen KiweluRachel Manongi,Blandina Mmbaga,Saidi Kapiga Jesus Gonzalez,Ravindra Gupta,Nick Grayson  December,2021
44Translation research into policy and practice: Scaling up evidence-based multiple focus integrated intensified TB screening to end TB(EXIT TB) in the East African regionBlandina MmbagaEsther Ngadaya,Sayoki Godfrey Mfinanga,Godfather Dickson Kimaro,Sokoine Kivuyo,Mbazi Senkoro,Amosi Kahwa,Ramadhani Shemtandulo,Godbless Charles Mbua,Bernard Ngowi Sara Moses Marwerwe,Hadija Hamisi Semvua  Ongoing
45Pyrethroid resistance PBO impregnated blankest for control on malaria in a humanitarian emergency situationJovin KitauFranklin Mosha,Joyce Wamoyi,Natacha Protopopoff  Ongoing
46Scale-up dementia screening and low resource interventions for dementia in older adults /depe studySarah UrasaRichard Walker,Declare Mushi,Irene Haule,Sarah Mkenda October,2017Ongoing
47Phase III evaluation of fludora ®fusion 56.25 wp. sp(clothianidin 50% + deltamethrin 6.25%) for indoor residual spraying for malaria vector control in Muheza,N.E TanzaniaMatt KirbyMark Rowland,Franklin Mosha,William KisinzaLSHTMOcober,2017October,2021
48Effect of dietary nitrate and folate supplementation on blood pressure in hypertensive Tanzanians.A feasibility studyGloria TemuBlandina Mmbaga,Declare MushiNew Castle University Ongoing
49Streamlining ethics review process and regulatory framework in Tanzania SMERTBlandina MmbagaNyanda Elias Ntinginya,Ruby Mcharo,Kissa Mwamwita,Joyce IkinguraEDTCP Ongoing
50An open-label partially randomized trial to evaluate the efficacy, safety, and tolerability of a 4-month treatment Bedaquiline plus moxifloxacin plus pyrazinamide(BPaMZ) compared to a 6-month treatment to HRZE/HR (Control) in adult participants with drug-sensitive smear-positive pulmonary  tuberculosis (DS-TB) NC 008(B-Pa-MZ) Trial- Simplici TBBlandina MmbagaElias Nyanda,Stella Mpagama,Hadija Semvua,Aliphonce liyoyo,Peter MmbeleleEDTCP  
51IMPAACT P1092: Phase IV Evaluation of the steady-state pharmacokinetics of zidovudine, lamivudine and lopinavir/ritonavir in severely malnourished HIV-1 Infected ARV-naïve children who are initiating HAARTAisa shayoBoniface Njau,Ann BuchananNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASEJul-10Jul-21
52Effectiveness of prevention package and model for predicting metabolic risk factors of type 2 diabetes among steet cooked food consumers in Dar es Salaam.Acluster randomized controlled trialGibson KagarukiMicheal Mahande,Sayoki Mfinanga,Esther Ngadaya,Daniel HaydonAfrique One ASPIREMay-18May,2021
53The holistic approach to unravel antibacterial resistance in East Africa (HATUA)Blandina Mmbaga EDTCPJuly,2018July,2021
54pharrmacovigilance in AfricaBlandina MmbagaHadija Semvua.Stella Mpagama,Kennedy Ngowi,Adam  Mitangu FimboEDTCPJul-18Jul-21
55Health Professionals Education  and Partnership Initiative (HEPI)Prof.Ephata KaayaKien A.Mteta,Pascalis Rugarabamu,John BartletNIHAug.2018Aug. 2021
56The effect and challenges of the implementation of differentiated HIV and AIDs service delivery in North-Eastern TanzaniaFuraha LyamuyaRachel Manongi ,Eva Muro and Terese KatzeinBSU IIIAug-18Aug. 2021
57Ondoilo: An increasing dialogue on family planning between Maasai and healthcare using interactive voice response callsDr.Sumari deboaerKennedy Ngowi,Blandina Mmbaga,Benjamin Shayo,Martha Oshiosen,Godfrey A.Kisigo,Eusebius Maro, Jacquiline Kwayu,Voice GlobalJul-18Aug. 2021
58A prospective cohort study on the incidence and predictors of severe altitude illness symptoms in Mount Kilimanjaro ClimbersGissella NyakungaMieke Croughs,Blandina Mmbaga,Kajiru Gad Kilonzo ,Francis Sakita and Patrick SoentjensInstitute of Tropical Medicine BelgiumAug-18Aug. 2021
59Randomized controlled noninferiority trial off topical chlorhexidine 0.2% versus topical natamycin 5% for fungal keratitis in East AfricaWilliam MakupaMathew Burton,Simon Arunga,Jeremy Hoffman,David Macleod,Helen Weiss,John Cairnes,Tara Mtuy,Tamsyn Derrick,Astrid Leck ,Paul VerweijWelcome TrustSeptember,2018Ongoing
60Xeroderma pigmentation in Tanzania. Clinical presentation, subtype, and incidence of tumors in a hospital-based cohortDavid MavuraGail Todd,Sia E.mMsuya Dec-18December,2021
61Determining the prevalence of disease other than tuberculosis in patients beginning treatment for smear-negative  tuberculosis in patients beginning treatment for smear-negative tuberculosisGissella Nyakunga  December,2018December,2021
62Human papillomavirus self-sampling and the use of telepathology in scaling up cervical cancer control in Kilimanjaro region, Northern TanzaniaAlexi MremiVibeke Rasch,Doris SchledermannBSU IIIDecember,2018December,2021
63Effectiveness and implementation of EVriMED for adherence to treatment among TB patients in Kilimanjaro TanzaniaMarion SumariBlandina  Mmbaga,Francis Pima,Kennedy Ngowi,Hadija Semvua,Stella Mpagama,Benson Mosha,Manase Chelangwa,Isaya Jelly,Pythia Nieuwkerk,Rob AarnoutseTB reach wave 6Dec-18Dec-21
64Supporting the National Action Plan for AMR (SNAP-AMR) in TanzaniaBlandina MmbagaElizabeth Msoka,Florida Muro,Stephen Mshana,Jeremiah Soni,Gabriel Shirima,Siana Mapunjo,Ruth Zadoks,Alicia Davis,Nick Hanley,Shona Hilton,Emma Laurie,Tiziana Lembo leviAntimicrobial resistance cross council(Medical Research Council and National Insitute for Health ResearchDecember,2018December, 2021
65Sexually transmitted infections and sexual behaviors among young adults attending higher learning institutions in Mbeya region, Tanzania Version 1.0, dated 12th July 2017Ruby Doryn McharoSia Msuya ,Phillipe MayaudTHRIVE-2December,2018Ongoing
66Health care workers experiences of antibiotic prescription in children  under five years, a qualitative study carried out in Moshi, TanzaniaMatilda EmgradSia E.MsuyaCentre of Antimicrobial resistance Research (CARe)Gothenburg University SwedenMar-19Mar-21
67NIHR global health research group on estimating the prevalence quality of life economic and societal impact of arthritis in TanzaniaBlandina MmbagaKajiiru Gad Kilonzo,Gloria Temu,Ireen Kiwelu,Elizabeth Msoka,Kiula Peter Kiula,Emma Sarah Mcintosh,I ain mclness,Sall Wyke,Dan Haydon,Sarah Cleveland,Stefan Sixbert,Jo Halliday,Christopher Bunn,Eleanor Grieve,Moira Aitken,Richard Wialker,Olive KellyEDTCPFeb-19February, 2021
68Assessment of temporal changes in Malaria epidemiology use of human antibody responses to mosquito and parasite antigens in North-East TanzaniaNancy Abdul KassamReginald Kavishe,Micheal Alifrangis,Christian William Wang,Christence SchmiegelowBSU 111FEB.2019February, 2021
69A5300B/12003B PhoENix Protecting households on exposure to newly diagnosed index Multidrug-resistant Tuberculosis Patients (PHOENix MDR TB)James Samwel NgochoAisa Shayo,Boniface Njau,Stella Mpagama,Dr.Hans Maro,Dr.Coleen CunninghamNICHD and  NIAIDMarch,2019Mar-21
70Silica and radon exposures and its associated effects on respiratory system among small scale Tanzanite miners in MereraniAlexander William MbuyaHadija semvua,Simon Henry Mamuya,Sia MsuyaDAAD ScholarshipApril,2019April,2021
71Open-label access to dolutegravir for HIV-1 infected children and adolescents completing IMPAACT study p1093Blandina MmbagaJames Ngocho,Boniface Njau,Coleen CunninghamGSK  
72Determining the prevalence of disease other than tuberculosis in patients beginning treatment for smear-negative tuberculosisGissella Nyakunganil November,2018November, 2021
73Active reporting of adverse drug reaction of antiretroviral drugs among adults living with HIV in East Africa: a pilot study on using SMSMarion SumariEva Muro, Blandina Mmbaga,Kennedy NgowiEACCR/EDTCPMay,2019May,2021
74Establishing and optimizing Illumina Miseq HIV-1 next-generation sequencing and drug resistance mutations testing at the KCRI biotechnology laboratory, Kilimanjaro regionHappiness KumburuIreen Kiwelu,Blandina Mmbaga,John Bartlet,Marco Van ZwetselaarDuke UniversityJune,2019July,2021
75Diagnosing children and young adults with suspected lymphoma in East Africa: Comparison of conventional pathology with digital scans and liquid biopsiesElifurah aMkwizuOliver Henke,Mramba Nyindo,Alexi Mremi,Furaha Serventi,Esther MajaliwaNational Institue of Health ResearvhJune,2019July,2021
76Prevalence and characteristics of patients with chronic lymphocytic leukemia a referral hospital in Tanzania.A hospital-based approach towards a hematologic malignancy in tropical AfricaOliver HenkeElifuraha Mkwizu,Mramba Nyindo,Furaha Servent,MapendoMwakipundaself fundedJune,2019July,2021
77Obtaining peripheral blood samples from HIV infected persons for standardization of virology quality assurance assaysPhiloteus SakasakaBlandina Mmbaga,Mathew RubachUS National Institute of HealthJul-19July,2021
78NOHA: an alternative to IHC in distinguishing ER – from ER+ breast cancer in the low resource settingFuraha ServentiBlandina Mmbaga,Sylvia Kilenga,Alexi MremiUniversity of EnglandJul-19Jul-21
79Microbiological characteristics of isolates causing asymptomatic bacteriuria in HIV infected patients attending care and treatment clinic (CTC) at KCMC HospitalBartholomeo NicholausA.K.MtetaTHETI-HEPI (PEPFARJul-19Jul, 2021
80The spectrum of cancers among people living with HIV in Tanzania: A retrospective hospital-based  in Tanzania: A retrospective  hospital-based studyAlexi MremiJohn Bar tlet and Blandina MmbagaTHETI-HEPI (PEPFAR)Jul-19 July, 2021
81To evaluate the effect of HIV infection and combined antiretroviral therapy on born turnover markers (BTMS) and bone mineral density in people living with HIVHonest MassaweFuraha Lyamuya and John BartlettTHETI-HEPI (PEPFAR)Jul-19Ongoing
82Strengthening caregiver networks to improve youth mental health outcomesSarah UrasaNeely Myers,Emmanuel Bujulu Jul-19Jul-21
83Capacity-building towards the development of a gametocyte based vaccine and gametocyte rapid diagnostic testsJaffu ChilongolaSixbert Mkumbaye,Pius HorumpendeCOSTECHJul-19Jul, 2021
84Formative research to assess needs, examine outcomes, and inform future training intervention for Community based HIV services in Moshi, TanzaniaBrandton KettelBlandina Mmbaga ,Melisa WattDuke Global Health InstituteJul-19Jul-21
85Effectiveness of MITS in establishing the cause of deathAlexi MremiMathew Rubach ,Mramba Nyindo,Ronald Mbwasi ,Elichilia Shao,Cristina Costales Blandina MmbagaMITS surveillance alliance North Carolina,USAJul, 2019Jul, 2021
86Chronic kidney diseases of unknown etiology (proportion, attributable factors,clinical and histopathological presentations) in adult patients, Northern TanzaniaKajiru Kilonzo THETI-HEPI (PEPFAR)Jul, 2019Jul, 2021
87Foodborne disease epidemiology, surveillance, and control in Africa low and middle-income countriesBlandina MmbagaKate Thomas and Tine HaldBill and Melinda Gates foundationAugust, 2019Aug. 2021
88Evaluation of pharmacokinetics and safety/tolerability of higher doses rifampicin in children with newly diagnosed uncomplicated tuberculosisHadija SemvuaGrace Kinabo, Rob Aarnoutse, Blandina Mmbaga, Stella Mpagama and Arnold NdaroRadboud UniversityAug-19Aug. 2021
89The impact of urbanization on plasma metabolome, transcriptome on innate immune responses, and coagulation in healthy Tanzanian individualsGodfrey Stephano TembaBlandina Mmbaga, Andre Vandervan, Quirijn  de MastRadboud Research Revolving FundsOctober, 2019October, 2021
90Epidemiology, clinical characteristics and treatment (HAART) response in HIV patients with Taenia Soliun neurocysticercosis from southern highlands, TanzaniaCharles Elias Makasi CYSTINET AFRICAOctober, 2019October, 2021
91A pragmatic randomized adaptive clinical trial to investigate controlling alcohol-related harms in a low-income setting: Emergency department brief intervention in TanzaniaBlandina MmbagaFrancis Sakita, Kennedy Ngowi, Catherine Staton , Joa0 Ricardo, Nickening Vissoci, Ashler PhilipsNIHOctober, 2019October,2021
93Urine coulometry for Tuberculosis pharmacokinetics evaluation in Tanzanian childrenBlandina MmbagaEstomih Mduma, Vick Farajael, Tania Thomas and Scot HeyshellUniversity of VirginiaOctober, 2019October, 2021
94The use of single nucleotide polymorphisms (SNPs) in P.falciparum apicoplast and mitochondria genomes in studying originality and distribution patterns of relevance for surveillance of antimalarial drug resistance in TanzaniaSixbert MkumbayeReginald Kavishe, Michael AlifrangisBSU IIIDecember, 2019December, 2021
95Application of novel molecular technologies for characterization etiology of emerging infectious disease in people presumed with bloodstream infections in TanzaniaShaban Ramadhan Mziraystella Mpagama, Jaffu chilongola, Tolbert SondaEDCTP and NIHERDecember, 2019December, 2021
96Glaucoma Detection Study (GDS)- Detecting glaucoma using a combination of low-cost portable and easily perform the testEinoti MatayanWilliam Makupa, Karin knollLondon School of Hygiene and Tropical MedicineDecember, 2019December,2021
97Reducing an emerging health threat in Tanzania: Study to examine and assess the seroprevalence, risks, and incidence of Crimean Congo hemorrhagic fever and another zoonotic disease in TanzaniaBlandina Mmbaga Ecohealth ProgrammeFebruary, 2020February, 2021
98Risk and preventive factors for the development of atopy and asthma in Tanzania (RIPA2TAN)Gissela NyakungaBlandina Mmbaga, Alice Andongolile, John Shao, Elichilia Shao, Upendo Matoli, David Minja ,Nateiya Yongolo, Harald Renzi, Kenny Claus, Chrysanthi Skevaki and Christian KreiselPhilipps, Universtat MarburgMar-20Mar-21
99Prevention of antibiotic resistance by TARGETED treatment pneumonia in childrenBlandina Mmbaga EDCTPApril, 2020Apr-21
100 A model for integrating clinical management of patients with dual tuberculosis and diabetes mellitus in TanzaniaNyasatu Godfrey ChambaRachel Manongi, Stella Mpagama,Kaushiki Ramaiya Tb Christian Byberg, Dirk ChristensenDANIDA through ADEPT programmeJune, 2020June, 2021
101Optimizing diagnosis and treatment outcomes of dual tuberculosis and diabetes mellitus in TanzaniaKenneth C. ByashaliraBlandina MmbagaDANIDA through ADEPT programmeJune, 2020Ongoing
102IMPAACT P2026S: Pharmacokinetics properties of antiretroviral and antituberculosis drugs during pregnancy and postpartumPendo MlayJames Ngocho, Boniface NjauNIADJune, 2020Jul-21
103Evaluation of the feasibility, accuracy, and effect of a rapid point of care serological triage test for active TB in high burden, HIV endemic African Settings: A multicentre, parallel, group, randomized controlled trial ( SeroSELECT)Balthazari NyombiCarol Hol Hansen, Grant Theron, Kidist Bobosha, Nick Borain, Tim Welsink , Aleksander Jusifoski, Fatima GruzkaNIPH, EDTCPJuly, 2020Jul, 2021
104Comprehensive eye care programme using technology  for screening in Northern TanzaniaFurahini Mndeme CBMOctober, 2020October, 2021
105Patient s quality of life, quality of care and treatment outcomes, and family experiences of caring for cancer patients in TanzaniaPaulo Lino Kidayi Private ( PhD candidate)August, 2020Aug. 2021
106A Phase Iib, open-label randomized controlled dose-ranging multicentre trial to evaluate the safety, tolerability, pharmacokinetics, and exposure-response relationship  of different doses of sutezoid in combination with bed quite, Delamanid and moxifloxacin in adult subjects with newly diagnosed, uncomplicated smear-positive, Drug sensitive Pulmonary Tuberculosis Short title : PANACEA Sutezoloid Dose finding and Combination Evaluation (SUDOCU)Stella MpagamaBlandina Mmbaga, Aliphonce Liyoyo and Peter MbeleleEDCTPNovember, 2020November, 2021
107A randomized double-blind placebo-controlled trial of rifapentine and isoniazid for prevention of tuberculosis in people living  with Diabetes in Tanzania and Uganda (PROTID)Nyasatu Godfrey ChambaKajiru Kilonzo, Hadija Semvua, Blandina Mmbaga, Sweetness laizer Issa Sabi, Nyanda NtinginyaEDCTPOctober, 2020Ongoing
108Quality of maternal care; risk factors and associated birth outcomes among pregnant women with preeclampsia in Unguja Zanzibar ( A  Community and Health Facility-based study)Nassra Ishak YussufRachel Manongi, Michael MahandeMinistry of Finance ZanzibarSeptember, 2020Ongoing
109The inflammatory and metabolic effect of a 2 weeks food change between traditional Tanzanian and western food change between traditional Tanzanian and western type foods in healthy Tanzanian male individual- DIET studyVesla KullayaBlandina Mmbaa, Reginald Kavishe, Godfrey Temba, Mary Mosha, Quirjn Mast  Andre Van der ven, Joachim L. Schultze, Paolo Lionetti, MihaiRadboud University Medical CentreSeptember, 2020September, 2021
120Mortality from Bacteria Infections Resistant to Antibiotics (MBIRA)Tolbert SondaHappiness Kumburu and Blandina MmbagaBill and Melinda Gates FoundationOctober,2020October,2021
121One health approach to transboundary disease surveillance and molecular epidemiologic analysis of brucellosis in Tanzania and RwandaBlandina MmbagaJaffu Chilongola, Venance MaroThe Defense Threat Reduction AgencyOctober, 2020Oct-21
122Phase 11b, open-label, randomized controlled dose ranging multicentre trial to evaluate the safety tolerability,pharmacokinetics and exposure-response relationship of different pelpazolid in combination with bedaquiline, delamanid and moxifloxacin in adult subjects with newly diagnosed, uncomplicated,smear-positive drug-sensitive pulmonary Tuberculosis: PANACEA Delpazolid dose-finding and COmbination DEvelopmentStella MpagamaBlandina MmbagaUniversity Hospital MunichOctober,2020October, 2021
123STRIPE (Strengthening Inter-Professional HIV Education)Alfred Mteta UCSF SubcontractApril 2020September 2021
124THRiVE IISia Msuya African Academy of Sciences  
125EEISHEA (Enhancing Entrepreneurship, Innovation & Sustainability in Higher Education in Africa)Declare Mushi European Union20182021
126STOP VIOLENCE PROJECT 2Declare Mushi GIZ/Heidelberg University Germany20212022
127BSU 3 – Building Stronger University ProjectElton Kisanga DANIDA20172021
128Efficacy of different types of bi-treated long-lasting insecticidal nets and deployment strategy for control of malaria transmitted by pyrethroid-resistant vectors (PAMVERC)Franklin Mosha Global Health Trial: British MRC/ DIFID/WELCOME Trust/LSHTM20182022
129HEPI/THET (To Reach the People: Transforming Health Professions Education in Tanzania)Alfred Mteta Fogarty Program through Health Professional Education Partnership Initiative (HEPI)20182023
130SACCABMichael MahandeSia MsuyaDELTA20182020
131Strengthen Research Capacity for Junior Faculties in Tanzania(MEPI JF)Alfred Mteta NIH20162020
132Evaluation of the Feasibility, Accuracy, And Effect of A Rapid Point-of-Care Serological Triage Test for Active TB (SeroSelectTB) in High Burden, HIV-Endemic African Settings: A Multi-Centre, Parallel-Group, Randomized, Controlled TrialBalthazar NyombiHadija SemvuaEDCTP20212024
133Predicting vector-borne disease epidemics: Dissemination of risk forecasting using District Health Information Software2 in Tanzania – PreVBDReginald KavisheBlandina MmbagaDANIDAJune 2020May 31 2025
134Implementing Simulation–Based Education in Malawi and Tanzania (NORHED II)Jane RogathiPaul KidayNORAD20212025
135Use of an Aedes Salivary Biomarker to Assess Arboviral Disease Transmission Risk and Efficacy of Vector Control in North-Eastern Tanzania – SABIOTDebora Kajeguka EDCTPFebruary 2021February 2023